Common TitleHPTN 083-1 (Adolescents)
Official Title Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males - A Sub-study of HPTN 083
Purpose / DescriptionThe purpose of this study is to establish the minimum safety, tolerability and acceptability data needed to support the use of cabotegravir long-acting injection (CAB LA) in an adolescent population, potentially transforming the field of HIV prevention for young people.
Phase Phase II
ClinicalTrials.gov NCT04692077
Funding
IndustryViiV Healthcare
Non-IndustryNational Institute of Allergy and Infectious Diseases